Related Experiment Videos
Therapeutic hepatic vein angioplasty for Budd-Chiari syndrome
Cardiovascular and Interventional Radiology
|January 1, 1986
Insights
Budd-Chiari syndrome, a liver condition, was successfully treated using percutaneous transluminal angioplasty (PTA). This minimally invasive procedure opened blocked hepatic veins, restoring blood flow and offering a new treatment option.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Hepatology
Background:
- Budd-Chiari syndrome is a rare hepatic vascular disease characterized by obstruction of hepatic venous outflow.
- Treatment options for Budd-Chiari syndrome can be limited, especially in complex cases involving multiple hepatic veins.
Observation:
- The case involved occlusion of three major hepatic veins with significant collateral formation to the inferior vena cava via the right inferior hepatic vein (RIHV).
- Stenosis at the ostium of the RIHV was identified as a critical factor contributing to the obstruction.
Findings:
- Percutaneous transluminal angioplasty (PTA) was performed to address the stenosis of the RIHV ostium.
- The PTA procedure was technically successful, achieving adequate dilation of the stenotic lesion.
Implications:
- This case demonstrates the efficacy of PTA as a minimally invasive treatment for complex Budd-Chiari syndrome.
- Successful PTA may offer a viable alternative to more invasive surgical interventions, improving patient outcomes.
Abstract:
The authors report a case of Budd-Chiari syndrome treated by percutaneous transluminal angioplasty (PTA). In this case, the occlusion of three major hepatic veins with a big collateral to the inferior vena cava via the right inferior hepatic vein (RIHV) and stenosis of the ostium of RIHV were seen. We performed successful PTA of this stenosis.